Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
Recruiting · NCT05326295 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
CTC detection
What this trial is about
The phenotype of circulating tumor cells (CTCs) is supposed to be significant indicator that is correlated the prognosis of breast cancer patients who have completed neoadjuvant chemotherapy, primary tumor surgery with/without adjuvant chemotherapy. The aim of this observational study is to assess the efficacy of CTCs surveillance in predicting the prognosis of breast cancer patients.
Who can take part
Age range
18 Years to 75 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- The age is more than 18 years old;
- Pathology confirmed malignant breast tumor;
- No clinical diagnosis of other malignancies, unstable complications or uncontrolled infection;
- Life expectancy is greater than 6 month;
- The main organ function is normal;
- The subjects volunteered to participate in this study, signed informed consent, followed up with good compliance.
Exclusion criteria
- Patients who had suffered from other malignant tumors;
- With uncontrolled bacterial, viral or fungal infections;
- With physical or mental disorders
- Without or limited civil capacity;
- Infected with human immunodeficiency virus (HIV)；
- Circumstances in which the investigator considers it inappropriate to participate in this study.
Where it is running
1 location listed.
- Hunan Cancer Hospital - Changsha, Hunan, China